Yuanyan Wei

1.2k total citations
35 papers, 949 citations indexed

About

Yuanyan Wei is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Yuanyan Wei has authored 35 papers receiving a total of 949 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 17 papers in Oncology and 10 papers in Immunology. Recurrent topics in Yuanyan Wei's work include Glycosylation and Glycoproteins Research (17 papers), Cancer Cells and Metastasis (13 papers) and Galectins and Cancer Biology (6 papers). Yuanyan Wei is often cited by papers focused on Glycosylation and Glycoproteins Research (17 papers), Cancer Cells and Metastasis (13 papers) and Galectins and Cancer Biology (6 papers). Yuanyan Wei collaborates with scholars based in China. Yuanyan Wei's co-authors include Jianhai Jiang, Jianxin Gu, Yang Xing, Xiaoning Chen, Chanjuan Liu, Yinan Li, Xiaojing Yun, Chunhong Cui, Yingchao Liu and Guoqiang Wu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Molecular and Cellular Biology.

In The Last Decade

Yuanyan Wei

35 papers receiving 945 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuanyan Wei China 20 657 373 204 200 115 35 949
Evangeline Mose United States 18 563 0.9× 551 1.5× 239 1.2× 283 1.4× 123 1.1× 25 1.2k
Alexandra Florin Germany 19 691 1.1× 388 1.0× 302 1.5× 123 0.6× 129 1.1× 27 1.1k
Marie Zipser Switzerland 11 849 1.3× 607 1.6× 135 0.7× 215 1.1× 165 1.4× 12 1.2k
Marcus Bosenberg United States 13 801 1.2× 384 1.0× 322 1.6× 188 0.9× 142 1.2× 20 1.2k
Christine Gjerdrum Norway 3 514 0.8× 488 1.3× 158 0.8× 385 1.9× 148 1.3× 6 1.1k
Alexander D. Boiko United States 12 683 1.0× 631 1.7× 246 1.2× 295 1.5× 142 1.2× 13 1.1k
Maya Zigler United States 17 565 0.9× 300 0.8× 184 0.9× 273 1.4× 93 0.8× 23 961
Jean‐Philippe Brosseau Canada 14 604 0.9× 304 0.8× 200 1.0× 248 1.2× 95 0.8× 24 1.2k
Karina J. Yoon United States 18 777 1.2× 409 1.1× 168 0.8× 128 0.6× 63 0.5× 48 1.1k
Michele Dziubinski United States 14 545 0.8× 547 1.5× 172 0.8× 141 0.7× 51 0.4× 17 890

Countries citing papers authored by Yuanyan Wei

Since Specialization
Citations

This map shows the geographic impact of Yuanyan Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanyan Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanyan Wei more than expected).

Fields of papers citing papers by Yuanyan Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuanyan Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanyan Wei. The network helps show where Yuanyan Wei may publish in the future.

Co-authorship network of co-authors of Yuanyan Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Yuanyan Wei. A scholar is included among the top collaborators of Yuanyan Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuanyan Wei. Yuanyan Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wei, Yuanyan, Qihang Chen, Chenhao Zhou, et al.. (2023). Loss of α-1,2-mannosidase MAN1C1 promotes tumorigenesis of intrahepatic cholangiocarcinoma through enhancing CD133-FIP200 interaction. Cell Reports. 42(12). 113588–113588. 6 indexed citations
2.
3.
Ji, Zhi, Qihang Chen, Yuanyan Wei, et al.. (2023). Siglec15 promotes the migration of thyroid carcinoma cells by enhancing the EGFR protein stability. Glycobiology. 33(6). 464–475. 5 indexed citations
4.
Wei, Yuanyan, Qihang Chen, Yingchao Liu, et al.. (2022). The Interaction between DNMT1 and High‐Mannose CD133 Maintains the Slow‐Cycling State and Tumorigenic Potential of Glioma Stem Cell. Advanced Science. 9(26). e2202216–e2202216. 28 indexed citations
5.
Liang, Ziwei, Zhi Ji, Wei-Tao Liu, et al.. (2021). The binding of LDN193189 to CD133 C-terminus suppresses the tumorigenesis and immune escape of liver tumor-initiating cells. Cancer Letters. 513. 90–100. 14 indexed citations
6.
Wei, Yuanyan, Ziwei Liang, Yuming Liu, et al.. (2019). IL-17A secreted from lymphatic endothelial cells promotes tumorigenesis by upregulation of PD-L1 in hepatoma stem cells. Journal of Hepatology. 71(6). 1206–1215. 50 indexed citations
7.
Cui, Chunhong, Xiaoning Chen, Ying Liu, et al.. (2017). β1,4-Galactosyltransferase V activates Notch1 signaling in glioma stem-like cells and promotes their transdifferentiation into endothelial cells. Journal of Biological Chemistry. 293(6). 2219–2230. 17 indexed citations
8.
Ge, Yuqing, Fengbiao Zhou, Hong Chen, et al.. (2010). Sox2 is translationally activated by eukaryotic initiation factor 4E in human glioma-initiating cells. Biochemical and Biophysical Research Communications. 397(4). 711–717. 30 indexed citations
9.
Wei, Yuanyan, Fengbiao Zhou, Yuqing Ge, et al.. (2010). β1,4-Galactosyltransferase V regulates self-renewal of glioma-initiating cell. Biochemical and Biophysical Research Communications. 396(3). 602–607. 14 indexed citations
10.
Xu, Jiejie, Xiaojing Yun, Jianhai Jiang, et al.. (2010). Hepatitis B Virus X Protein Blunts Senescence-Like Growth Arrest of Human Hepatocellular Carcinoma by Reducing Notch1 Cleavage. Hepatology. 52(1). 142–154. 68 indexed citations
11.
Wei, Yuanyan, Dan Liu, Fengbiao Zhou, et al.. (2008). Identification of β-1,4-galactosyltransferase I as a target gene of HBx-induced cell cycle progression of hepatoma cell. Journal of Hepatology. 49(6). 1029–1037. 28 indexed citations
12.
Wei, Yuanyan, Jianhai Jiang, Dan Liu, et al.. (2008). Cdc34-mediated Degradation of ATF5 Is Blocked by Cisplatin. Journal of Biological Chemistry. 283(27). 18773–18781. 20 indexed citations
13.
14.
Jiang, Jianhai, Yuanyan Wei, Dan Liu, et al.. (2007). E1AF promotes breast cancer cell cycle progression via upregulation of Cyclin D3 transcription. Biochemical and Biophysical Research Communications. 358(1). 53–58. 31 indexed citations
15.
Jiang, Jianhai, Jin Zhou, Yuanyan Wei, et al.. (2007). β4GalT-II increases cisplatin-induced apoptosis in HeLa cells depending on its Golgi localization. Biochemical and Biophysical Research Communications. 358(1). 41–46. 4 indexed citations
16.
17.
Chen, Xiaoning, Jianhai Jiang, Chun Chen, et al.. (2006). Down-regulation of the expression of β1,4-galactosyltransferase V promotes integrin β1 maturation. Biochemical and Biophysical Research Communications. 343(3). 910–916. 14 indexed citations
18.
Jiang, Jianhai, Xiaoning Chen, Jia-Lin Shen, et al.. (2006). β1,4-Galactosyltransferase V Functions as a Positive Growth Regulator in Glioma. Journal of Biological Chemistry. 281(14). 9482–9489. 32 indexed citations
19.
Sun, Maoyun, Yuanyan Wei, Luyang Yao, et al.. (2005). Identification of extracellular signal-regulated kinase 3 as a new interaction partner of cyclin D3. Biochemical and Biophysical Research Communications. 340(1). 209–214. 15 indexed citations
20.
Wei, Yuanyan, Jianhai Jiang, Maoyun Sun, et al.. (2005). ATF5 increases cisplatin-induced apoptosis through up-regulation of Cyclin D3 transcription in HeLa cells. Biochemical and Biophysical Research Communications. 339(2). 591–596. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Evangeline Mose Breakdown of academic impact, for papers by Alexandra Florin Breakdown of academic impact, for papers by Marie Zipser Breakdown of academic impact, for papers by Marcus Bosenberg Breakdown of academic impact, for papers by Christine Gjerdrum Breakdown of academic impact, for papers by Alexander D. Boiko Breakdown of academic impact, for papers by Maya Zigler Breakdown of academic impact, for papers by Jean‐Philippe Brosseau Breakdown of academic impact, for papers by Karina J. Yoon Breakdown of academic impact, for papers by Michele Dziubinski
Rankless by CCL
2026